Cargando…
Factor-inhibiting HIF (FIH) promotes lung cancer progression
Factor-inhibiting HIF (FIH) is an asparagine hydroxylase that acts on hypoxia-inducible factors (HIFs) to control cellular adaptation to hypoxia. FIH is expressed in several tumor types, but its impact in tumor progression remains largely unexplored. We observed that FIH was expressed on human lung...
Autores principales: | García-del Río, Ana, Prieto-Fernández, Endika, Egia-Mendikute, Leire, Antoñana-Vildosola, Asier, Jimenez-Lasheras, Borja, Lee, So Young, Barreira-Manrique, Adrián, Zanetti, Samanta Romina, de Blas, Ander, Velasco-Beltrán, Paloma, Bosch, Alexandre, Aransay, Ana M., Palazon, Asis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619494/ https://www.ncbi.nlm.nih.gov/pubmed/37707961 http://dx.doi.org/10.1172/jci.insight.167394 |
Ejemplares similares
-
Hypoxia Promotes Syndecan-3 Expression in the Tumor Microenvironment
por: Prieto-Fernández, Endika, et al.
Publicado: (2020) -
Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate
por: Prieto-Fernández, Endika, et al.
Publicado: (2021) -
A flow cytometry-based neutralization assay for simultaneous evaluation of blocking antibodies against SARS-CoV-2 variants
por: Egia-Mendikute, Leire, et al.
Publicado: (2022) -
Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals
por: Egia-Mendikute, Leire, et al.
Publicado: (2021) -
Structural insights into Siglec-15 reveal glycosylation dependency for its interaction with T cells through integrin CD11b
por: Lenza, Maria Pia, et al.
Publicado: (2023)